Sign inJoin waitlistJoin the waitlist

David Ollila

, Director and Professor of Surgery · University of North Carolina Hospitals

Credentials: · · ·

History

Department of Surgery · University of North Carolina Hospitals
Present
University of North Carolina Hospitals
Present
University of North Carolina Hospitals
Present

John Wayne Cancer Institute
1995–1997
Surgery
Riverside Methodist Hospitals
1990–1995
University of Cincinnati College of Medicine
1986–1990

Research

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes
Clinical Cancer Research · 2007 · 1,643 citations
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011…
JAMA · 2017 · 1,491 citations
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial
JAMA · 2013 · 1,241 citations

Nancy Thomas
44 papers
Michael Meyers
29 papers · 5 as a resident
KB
Klaus Busam
22 papers
Kristalyn Gallagher
22 papers · 15 as a resident
Frances Collichio
21 papers
Karyn Stitzenberg
21 papers · 6 as a fellow
CS
Carolyn Sartor
16 papers
Lisa Carey
16 papers
Stergios Moschos
16 papers
Paul Googe
15 papers
PG
Pamela Groben
13 papers
Philip Spanheimer
13 papers · 7 as a resident

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $95.1K · Univ of North Carolina Chapel Hill
2003–2006

Clinical trials

Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery
Principal investigator · Completed · Phase 2
UNC Lineberger Comprehensive Cancer Center
2002–2006
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Site PI · Recruiting
Melanoma and Skin Cancer Trials Limited
2019–2034